Alvotech secures $100 million term loan facility
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Alvotech Secures Term Loan Facility of USD 100 Million
December 31, 2025 4:30 PM ESTUSD 100 million senior term loan facility with a 2-year maturityStrengthens liquidity to support execution across Alvotechs R&D pipeline and global product launches through 2026Led by GoldenTree Asset Management
REYKJAVIK, ICELAND (December 31, 2025) Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced a USD 100 million senior term loan facility with maturity... More



